190 related articles for article (PubMed ID: 28677170)
21. GNAS mutations in primary mucinous and non-mucinous lung adenocarcinomas.
Ritterhouse LL; Vivero M; Mino-Kenudson M; Sholl LM; Iafrate AJ; Nardi V; Dong F
Mod Pathol; 2017 Dec; 30(12):1720-1727. PubMed ID: 28776576
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas.
Kondo T; Nakazawa T; Ma D; Niu D; Mochizuki K; Kawasaki T; Nakamura N; Yamane T; Kobayashi M; Katoh R
Lab Invest; 2009 Jul; 89(7):791-9. PubMed ID: 19506552
[TBL] [Abstract][Full Text] [Related]
23. Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.
Vincenten J; Smit EF; Vos W; Grünberg K; Postmus PE; Heideman DA; Snijders PJ; Meijer G; Kuik J; Witte BI; Thunnissen E
J Thorac Oncol; 2012 Oct; 7(10):1522-7. PubMed ID: 22982653
[TBL] [Abstract][Full Text] [Related]
24. The complexity of thyroid transcription factor 1 with both pro- and anti-oncogenic activities.
Mu D
J Biol Chem; 2013 Aug; 288(35):24992-25000. PubMed ID: 23818522
[TBL] [Abstract][Full Text] [Related]
25. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
26. CDX-2 Expression in Primary Lung Adenocarcinoma.
Cowan ML; Li QK; Illei PB
Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):16-9. PubMed ID: 26469326
[TBL] [Abstract][Full Text] [Related]
27. KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinoma.
Rekhtman N; Ang DC; Riely GJ; Ladanyi M; Moreira AL
Mod Pathol; 2013 Oct; 26(10):1307-19. PubMed ID: 23619604
[TBL] [Abstract][Full Text] [Related]
28. Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.
Kadota K; Yeh YC; D'Angelo SP; Moreira AL; Kuk D; Sima CS; Riely GJ; Arcila ME; Kris MG; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Aug; 38(8):1118-27. PubMed ID: 25029118
[TBL] [Abstract][Full Text] [Related]
29. LKB1 loss by alteration of the NKX2-1/p53 pathway promotes tumor malignancy and predicts poor survival and relapse in lung adenocarcinomas.
Tsai LH; Chen PM; Cheng YW; Chen CY; Sheu GT; Wu TC; Lee H
Oncogene; 2014 Jul; 33(29):3851-60. PubMed ID: 23995788
[TBL] [Abstract][Full Text] [Related]
30. The relationship between TTF-1 expression and EGFR mutations in lung adenocarcinomas.
Shanzhi W; Yiping H; Ling H; Jianming Z; Qiang L
PLoS One; 2014; 9(4):e95479. PubMed ID: 24743427
[TBL] [Abstract][Full Text] [Related]
31. EGFR mutation is specific for terminal respiratory unit type adenocarcinoma.
Yatabe Y; Kosaka T; Takahashi T; Mitsudomi T
Am J Surg Pathol; 2005 May; 29(5):633-9. PubMed ID: 15832087
[TBL] [Abstract][Full Text] [Related]
32. Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1.
Tanaka H; Yanagisawa K; Shinjo K; Taguchi A; Maeno K; Tomida S; Shimada Y; Osada H; Kosaka T; Matsubara H; Mitsudomi T; Sekido Y; Tanimoto M; Yatabe Y; Takahashi T
Cancer Res; 2007 Jul; 67(13):6007-11. PubMed ID: 17616654
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.
Matsubara D; Kishaba Y; Ishikawa S; Sakatani T; Oguni S; Tamura T; Hoshino H; Sugiyama Y; Endo S; Murakami Y; Aburatani H; Fukayama M; Niki T
Cancer Sci; 2013 Feb; 104(2):266-73. PubMed ID: 23163725
[TBL] [Abstract][Full Text] [Related]
34. Transcriptome analysis reveals the essential role of NK2 homeobox 1/thyroid transcription factor 1 (NKX2-1/TTF-1) in gastric adenocarcinoma of fundic-gland type.
Fukagawa K; Takahashi Y; Yamamichi N; Kageyama-Yahara N; Sakaguchi Y; Obata M; Cho R; Sakuma N; Nagao S; Miura Y; Tamura N; Ohki D; Mizutani H; Yakabi S; Minatsuki C; Niimi K; Tsuji Y; Yamamichi M; Shigi N; Tomida S; Abe H; Ushiku T; Koike K; Fujishiro M
Gastric Cancer; 2023 Jan; 26(1):44-54. PubMed ID: 36094595
[TBL] [Abstract][Full Text] [Related]
35. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
Li H; Pan Y; Li Y; Li C; Wang R; Hu H; Zhang Y; Ye T; Wang L; Shen L; Sun Y; Chen H
Lung Cancer; 2013 Jan; 79(1):8-13. PubMed ID: 23098378
[TBL] [Abstract][Full Text] [Related]
36. Thyroid transcription factor-1 (TTF-1) gene: identification of ZBP-89, Sp1, and TTF-1 sites in the promoter and regulation by TNF-α in lung epithelial cells.
Das A; Acharya S; Gottipati KR; McKnight JB; Chandru H; Alcorn JL; Boggaram V
Am J Physiol Lung Cell Mol Physiol; 2011 Oct; 301(4):L427-40. PubMed ID: 21784970
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive study of mutational and clinicopathologic characteristics of adenocarcinoma with lepidic pattern in surgical resected lung adenocarcinoma.
Xu Y; Zhu C; Qian W; Zheng M
J Cancer Res Clin Oncol; 2017 Jan; 143(1):181-186. PubMed ID: 27738759
[TBL] [Abstract][Full Text] [Related]
38. Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients.
Carneiro JG; Couto PG; Bastos-Rodrigues L; Bicalho MA; Vidigal PV; Vilhena A; Amaral NF; Bale AE; Friedman E; De Marco L
Genet Res (Camb); 2014; 96():e002. PubMed ID: 24594201
[TBL] [Abstract][Full Text] [Related]
39. Terminal respiratory unit type lung adenocarcinoma is associated with distinctive EGFR immunoreactivity and EGFR mutations.
Peterson MR; Piao Z; Bazhenova LA; Weidner N; Yi ES
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):242-7. PubMed ID: 17721266
[TBL] [Abstract][Full Text] [Related]
40. Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL; Watanabe H; Magendantz M; Hoersch S; Chen TA; Wang DG; Crowley D; Whittaker CA; Meyerson M; Kimura S; Jacks T
Mol Cell; 2013 Apr; 50(2):185-99. PubMed ID: 23523371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
